Adult ADHD Management

Pharmacological Treatment

The American Academy of Pediatrics recommends that stimulant medications, specifically methylphenidate and lisdexamfetamine, are the first-line pharmacological treatments for adult ADHD, with effectiveness rates of 70-80% 1
Long-acting formulations are strongly preferred due to better medication adherence, lower risk of rebound effects, and more consistent symptom control throughout the day 1
Amphetamine-based stimulants are preferred over methylphenidate based on comparative efficacy studies in adults 1
Atomoxetine is the established second-line option for adults who cannot tolerate or do not respond to stimulants, providing 24-hour symptom coverage without disrupting sleep-wake cycles 1
Alpha-2 adrenergic agonists, such as extended-release guanfacine or extended-release clonidine, can be used as adjunctive therapy with stimulants if monotherapy is insufficient, with effect sizes around 0.7 1

Cognitive Behavioral Therapy (CBT) is the most extensively studied and effective psychotherapy for adult ADHD, with increased effectiveness when combined with medication, focusing on time management, organization, planning, and adaptive behavioral skills 1
Mindfulness-Based Interventions (MBIs) show increasing evidence for managing adult ADHD, with most profound benefits occurring with inattention symptoms, emotion regulation, executive function, and quality of life 1

Anxiety does not contraindicate stimulant use but requires careful monitoring, and stimulants can indirectly reduce anxiety related to functional impairment by improving executive function deficits 1
Assessment for substance abuse symptoms is mandatory before initiating treatment, and when substance use is identified, assessment when off abusive substances should precede ADHD treatment 3

Regular vital sign monitoring (blood pressure, pulse) is necessary with stimulant use, and cardiovascular monitoring should be conducted regularly per American Heart Association recommendations 1
Effectiveness evaluation should be based on reduction in core ADHD symptoms and improvement in functional domains, with periodic reevaluation of long-term medication usefulness for the individual patient 1
The American Academy of Pediatrics recommends periodic reevaluation of long-term medication usefulness for the individual patient 2

Alpha-2 agonists can be used as adjunctive therapy when stimulant monotherapy provides insufficient response 1
Comorbid conditions may improve with ADHD treatment alone, so avoid premature addition of medications for comorbid symptoms, as recommended by the American Academy of Pediatrics 4